Image courtesy of Pexels.

Today, infectious diseases remain the leading source of preventable death around the world. Compounding this problem, reliable diagnostics are often difficult to access. Current methods can take time, and they cannot always detect diseases early enough for the best treatment outcomes.

Recently, researchers explored whether metabolomics could help identify infections sooner. Metabolomics is the study of small molecules called metabolites. These molecules can serve as biomarkers, showing signs of infection within the body.

To evaluate how well metabolomics works for disease detection, researchers conducted a systematic review and meta-analysis. Their review covered studies published from 2014 to 2025. Across these studies, researchers examined whether metabolomics biomarkers could accurately identify bacterial, viral, and parasitic infections.

In their findings, researchers showed that metabolomics biomarkers were reliable diagnostic aids. In particular, they showed promise in detecting diseases during early stages of infection. Accordingly, researchers suggest that metabolomics could become an additional tool alongside more traditional diagnostic methods.

Why Is Metabolomics a Promising Detection Tool?

In metabolomics, small molecule metabolites are carefully analyzed. These metabolites result from gene expression, cellular activity, and other biological processes. Unlike genomics and proteomics, metabolomics can show changes as they happen in real time.

As a result, metabolomics may be especially useful for identifying early infections. For instance, metabolic processes involving amino acids, lipids, and immune system activity can all be detected. These changes may provide important clues before symptoms become severe or harder to treat.

Previous research has shown the usefulness of metabolomics for diagnosis. However, there has been broad methodological inconsistency across studies. For this reason, the systematic review and meta-analysis helped researchers get a firmer grasp on its usefulness.

Because the studies examined bacteria, viruses, and parasites, the review offered a broad look at infectious diseases. Overall, researchers found that metabolomics biomarkers showed strong diagnostic capabilities across the 22 studies included in the analysis.

One interesting finding was that bacterial infections showed slightly greater diagnostic accuracy. Researchers propose that bacteria may cause unique changes in amino acids and other metabolic processes. These changes may be easier to detect through metabolomics.

Still, researchers note that more research is needed to understand this trend. Additional studies may also help explain why viral infections were slightly less predictable. Importantly, researchers tested for publication bias and found that their results were unlikely to be overstated.

What’s Next for Metabolomics in Disease Detection?

Beyond diagnosis alone, metabolomics could also help tailor patient care. By giving clinicians a clearer live snapshot of a patient’s metabolic profile, metabolomics may eventually support more personalized treatment decisions.

Still, researchers acknowledge important limitations. Most of the included studies were observational, which means some bias may remain. Differences in study procedures may also affect results.

Finally, many of the included studies had fairly small sample sizes. Future research should investigate unique disease profiles more rigorously. With further study, metabolomics may become a valuable tool for detecting infections earlier and guiding more effective care.

Conclusion

Metabolomics may help detect infections earlier than traditional diagnostic tools. Researchers found strong biomarker accuracy across many infectious disease studies. Further research could improve clinical use and personalized patient care.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Mikael Häggström, M.D..

For years, natural medicine and modern science have been framed as opposing forces. Many people are told to choose one side or the other. Yet research shows that some traditional remedies may hold real medical value when studied. A new example comes from turmeric and ginger, two plants used in cooking and healing traditions.

Researchers at Washington State University found that extracts from turmeric and ginger may improve bone implants. These findings suggest that ancient knowledge and modern engineering can sometimes work together.

What Were the Findings?

Bone implants are medical devices placed into damaged areas of the skeleton. They are often used after fractures, joint damage, or severe wear from age. Common examples include hip replacements and titanium supports used after injury. These implants can restore movement and reduce pain. However, they do not always succeed.

One major problem is poor bonding between the implant and the body. If the surrounding bone does not attach well, the implant may loosen or fail over time. Another serious issue is infection. Bacteria can grow on implant surfaces and create stubborn colonies that resist treatment. In many cases, infected implants must be removed and replaced. This process can be painful, expensive, and physically difficult for patients.

The research team tested a coating made from turmeric and ginger extracts on titanium implants. They designed the coating to slowly release useful compounds over time. This allowed the implant surface to interact with surrounding tissue in a more supportive way.

The results were striking. Within six weeks, coated implants bonded to bone at nearly twice the normal rate. This means the body accepted and integrated the implants far better than untreated versions. Stronger bonding may reduce loosening and increase long-term success.

The coating also showed strong antibacterial effects. It removed more than 90 percent of bacteria on the implant surface. This is important because infection remains one of the leading causes of implant failure. A safer implant surface could help many future patients avoid revision surgeries.

Researchers also studied osteosarcoma-related cells. Osteosarcoma is a dangerous bone cancer that often affects children, teens, and younger adults. Treatment can involve surgery and chemotherapy, yet complete removal is not always possible. In the study, the turmeric and ginger coating reduced cancer-related cells around the implant area. The effect showed eleven times fewer cancerous cells compared with untreated samples.

What’s Next?

Turmeric and ginger have been used for thousands of years in regions such as India and China. Traditional healers valued them for inflammation, digestion, and general wellness. Modern research has already shown that compounds in both plants can have anti-inflammatory and antioxidant effects. This new study adds another possible benefit.

The findings do not mean eating turmeric or ginger will repair a broken implant or cure cancer. Instead, they show how plant compounds may be transformed into targeted medical tools. Scientists still need human trials and further testing before widespread use.

Even so, the study offers a hopeful reminder. Sometimes wisdom from the past can help solve problems of the present. When traditional knowledge is tested through science, surprising breakthroughs may emerge.

Conclusion

Researchers found turmeric and ginger coatings helped bone implants bond and fight infection. The treatment also sharply reduced cancer-related bone cells in early testing. The study shows some traditional plant compounds may improve future medical implants.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

Sometimes important answers appear in unexpected and surprising places. People often find lost items hidden under cushions or inside drawers. Researchers discovered a similar surprise while studying vitamin D and COVID-19.

Scientists found regular vitamin D intake may reduce Long COVID risk. This finding came from researchers at Mass General Brigham. Their results were published in the Journal of Nutrition.

How Did Research Find the Link?

Earlier studies explored vitamin D because it supports immune system function. However, past research linking vitamin D and COVID-19 showed unclear results. Researchers designed this study to better understand that relationship.

They created the VIVID trial to study vitamin D and COVID-19. The study included adults recently diagnosed with COVID-19 and their families. Participants came from both the United States and Mongolia.

A total of 1,747 adult participants were included in the analysis. Additionally, 277 family members joined the study under separate conditions. These family members received either vitamin D3 supplements or a placebo daily.

Participants took supplements or a placebo for a period of four weeks. Most participants began supplementation about three days after testing positive.

The United States trial ran from December 2020 through September 2022. The Mongolia portion ran from September 2021 through April 2022.

Researchers used randomization to reduce bias across the study groups. They also adjusted for factors that could influence results. These included age, sex, body mass index, race, and ethnicity. Vaccination status was also considered as a possible influencing factor.

The study found no meaningful change in COVID-19 symptom severity. It also showed no reduction in the likelihood of virus transmission.

However, researchers noticed a possible connection to Long COVID outcomes. Participants taking vitamin D showed a slightly lower risk of symptoms.

These long-term symptoms were measured eight weeks after initial infection. Participants taking supplements had a 21 percent chance of symptoms. Those taking a placebo had a 25 percent chance of symptoms.

This represents a 4 percent reduction in Long COVID risk. The difference was considered barely statistically significant by researchers.

What’s Next?

Even so, the findings remain important for future investigation efforts. Long COVID can cause wide-ranging and serious long-term health effects.

Because of this, even small improvements may have meaningful impacts. Researchers believe this signal could guide future clinical studies.

Further research will help confirm whether vitamin D truly reduces risk. Scientists will need larger studies and stronger statistical evidence. For now, the findings offer a cautious but promising direction forward.

Conclusion

Vitamin D supplements did not reduce COVID-19 severity or spread. However, participants showed a small decrease in Long COVID risk. Researchers say more studies are needed to confirm these early findings.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

Each year, travelers face a changing landscape of health risks. In 2026, global travel, migration, and environmental changes continue to create new opportunities for infectious diseases to spread. Mosquito-borne illnesses are increasing in many regions. Meanwhile, vaccine-preventable diseases, once controlled, are returning in some parts of the world. Understanding these risks is essential for anyone preparing international travel plans.

Among the most significant concerns is dengue fever. Annually, up to 400 million people are infected with dengue worldwide. Of those infected, approximately one-quarter develop symptoms. Cases continue to rise across many regions. Dengue remains one of the most common mosquito-borne illnesses affecting travelers today.

What You Should Know about Dengue

Historically, dengue has been concentrated in Southeast Asia, South Asia, the Pacific Islands, Latin America, the Caribbean, and parts of Africa. But the virus is no longer confined to these traditional hotspots. Climate change, urbanization, and increasing international travel have expanded the range of mosquitoes capable of transmitting dengue. Researchers estimate that by 2100, as many as 8.4 billion people could face exposure to mosquito-borne diseases such as dengue and malaria.

The World Health Organization continues to classify dengue as a Grade 3 emergency. This designation is its highest level of emergency response. Today, dengue transmission occurs across approximately 110 countries. It affects nearly half of the world’s population.

Dengue is caused by a virus spread primarily through the bite of infected Aedes aegypti mosquitoes. Increasingly, Aedes albopictus, commonly known as the Asian tiger mosquito, is also contributing to transmission. Malaria-transmitting mosquitoes are often associated with nighttime exposure. However, dengue-carrying mosquitoes commonly bite during daylight hours.

The disease usually causes symptoms four to seven days after infection. Common signs include fever, headache, muscle pain, joint pain, nausea, and rash. Most people recover without complications. However, some infections become severe and can lead to dengue hemorrhagic fever. This is a potentially life-threatening condition involving bleeding, shock, and organ damage.

Because there is no specific treatment that cures dengue, prevention remains the most effective defense. Travelers should wear long sleeves and long pants whenever practical, use EPA-approved insect repellents, and stay in accommodations with screened windows, air conditioning, or mosquito nets.

It is also important to understand where dengue mosquitoes thrive. Unlike many people assume, Aedes mosquitoes are highly adapted to urban environments. They often breed in small collections of standing water around homes, hotels, and businesses. Even a bottle-cap-sized amount of stagnant water can provide a suitable breeding site. Travelers should avoid areas with standing water whenever possible, particularly during rainy seasons when mosquito populations tend to increase.

Other Travel Risks in 2026

While dengue receives significant attention, similar trends are affecting other mosquito-borne illnesses. Malaria, Zika virus, and West Nile virus continue to pose health concerns in many parts of the world. Although malaria is also spread by mosquitoes, it differs from dengue because it is caused by a protozoan parasite rather than a virus.

The geographic range of mosquito-borne diseases is also expanding. While dengue remains most common in tropical and subtropical regions, transmission is increasingly reported in areas of the Americas, including Puerto Rico, Hawaii, and parts of Florida. Some European countries are also experiencing growing numbers of locally acquired cases.

At the same time, vaccine-preventable diseases are creating additional concerns for travelers. Measles outbreaks have increased across portions of North America and Europe in recent years. Because measles is highly contagious, airports, train stations, cruise terminals, and other transportation hubs can become areas of elevated transmission risk.

Many travelers mistakenly assume childhood vaccinations provide lifelong protection without reviewing their immunization records. Before traveling, individuals should confirm that recommended vaccinations are current and discuss destination-specific vaccine requirements with a healthcare provider.

Polio presents another example of a disease many consider a historical threat. While global vaccination efforts dramatically reduced transmission, outbreaks continue to occur in some regions due to gaps in immunization coverage and international travel.

As travel patterns evolve, so do infectious disease risks. Taking preventive measures, staying current on vaccinations, and understanding local health conditions can help travelers reduce their risk and enjoy safer journeys in 2026.

Conclusion

Mosquito-borne diseases like dengue are spreading as climate change, travel, and urbanization expand mosquito habitats. Meanwhile, lower vaccination rates and unequal access are fueling outbreaks of measles and polio. Travelers can reduce risk by staying vaccinated and avoiding mosquito bites.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

In surprising findings, recent research has linked vaccines to lower dementia risk. Another recent study may help explain why this connection exists. Researchers found that severe infections may increase dementia risk years later. The findings suggest that preventing infections could help protect brain health.

The study included more than 62,000 older adults. Researchers recruited participants in 2016 and followed them through 2021. Participants were at least 65 years old when the study began. The average participant age was approximately 81 years old.

What Are the Findings?

Researchers compared participants diagnosed with dementia against a large control group. Nearly 313,000 control participants did not develop dementia during the same period. After analyzing the data, researchers identified 29 medical conditions associated with later dementia diagnosis. These conditions were diagnosed between one and 21 years before dementia appeared.

Importantly, the results remained significant even after accounting for other illnesses. Researchers found that dementia was much more common among participants with these conditions. The conditions covered a broad range of health problems. These included injuries, mental disorders, cardiovascular disease, neurological conditions, and endocrine disorders.

Among all participants, 47 percent experienced at least one linked condition. More than 20 percent developed two associated conditions. Some of the most common conditions included ischemic stroke, traumatic brain injury, and type 2 diabetes. However, not every condition carried the same level of risk.

Mental disorders showed some of the strongest associations with dementia. Researchers believe this may result from physical brain damage or other neurological changes. Parkinson’s disease and alcohol-related mental disorders also demonstrated particularly strong connections. Depending on the condition, diagnoses typically occurred five to 12 years before dementia developed.

Researchers also examined severe infections requiring hospital treatment. More than 65 percent of the studied diseases showed links to increased infection risk. Urinary tract infections, or UTIs, appeared especially important. Strong associations were found between UTI risk and conditions such as epilepsy, hemorrhagic stroke, and alcohol-related disorders.

What’s Next?

Scientists proposed several explanations for the connection between infections and dementia. One possibility involves inflammation triggered by severe infections. Other theories include immune system communication problems and harmful substances circulating in the blood. Researchers suggest these processes may gradually affect the brain over time.

Importantly, the findings do not suggest that infections directly cause dementia in most cases. Instead, severe infections may help create conditions that allow dementia to develop. Researchers describe this process as contributing to preclinical dementia. In other words, the disease process may begin long before symptoms appear.

To strengthen their findings, researchers analyzed participants by sex and education level. The associations remained consistent across these groups. However, the team acknowledged limitations. Some lifestyle behaviors and other factors could not be fully measured.

Dementia is typically diagnosed after age 80. Many older adults also have medical conditions that increase infection risk. Researchers believe their findings highlight the importance of preventing and treating serious infections. While the results are compelling, further studies are needed to determine whether prevention, treatment, or both offer the greatest protection against dementia.

Conclusion

Researchers found that severe infections may increase dementia risk years later. The findings suggest that infection-related inflammation could help create conditions that allow dementia to develop. More research is needed, but preventing and treating serious infections may help protect long-term brain health.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

In recent years, mosquito populations have expanded into traditionally cooler regions. Previously, many disease-carrying mosquitoes were concentrated in warmer climates. As global temperatures rise, however, some mosquito species are adapting to new environments and spreading farther north.

This shift has increased concerns about mosquito-borne illnesses in areas that historically faced fewer risks. As a result, researchers are searching for better ways to track mosquito populations and understand how they move.

A new study published in the journal PNAS Nexus explores one possible solution: harmonic radar tags.

Why Is Tracking Mosquitoes Important?

Mosquitoes transmit diseases that affect millions of people worldwide. These illnesses include malaria, West Nile virus, Zika virus, dengue fever, and yellow fever.

Understanding where mosquitoes travel and how they behave can help public health officials identify disease risks before outbreaks occur. Better tracking may also improve mosquito control efforts and reduce opportunities for disease transmission.

Researchers have successfully tracked larger animals for decades using physical tags. Birds, fish, and mammals are commonly monitored this way. Insects, however, present a much greater challenge because of their small size.

What Are Harmonic Radar Tags?

Harmonic radar tags, often called HR tags, are small devices that allow researchers to track insects using radio frequencies.

Scientists have used similar tags since the 1980s to monitor larger insects such as beetles, moths, bees, and wasps. Mosquitoes are much smaller, making the technology more difficult to adapt.

The tags themselves are relatively simple and inexpensive. Each tag contains two wires and a semiconductor diode. Researchers can assemble many of the components by hand.

For the study, scientists attached the tiny tags to the mosquitoes’ thoraxes, the section of the body located between the head and abdomen. After tagging the insects, researchers released them and monitored their movements using radar equipment.

How Well Did the Tags Work?

Researchers conducted 12 separate experiments in a variety of environments. These included laboratory settings, outdoor locations, coffee fields, and shaded parks. The tags successfully revealed differences in mosquito behavior across these environments.

For example, mosquitoes tended to fly lower in coffee fields where trees and vegetation created obstacles. In more open park settings, mosquitoes were able to travel higher and remain airborne longer.

These observations suggest that harmonic radar tags may provide valuable information about how mosquitoes move through different landscapes.

While the technology showed promise, researchers also identified significant limitations. The largest issue was survival. Approximately 60% of tagged mosquitoes died within 24 hours. This suggests that current tag designs still place considerable strain on the insects.

Scientists hope future improvements will reduce the weight and impact of the devices while maintaining tracking accuracy.

Researchers are also interested in adapting similar tags for other disease-carrying insects. One potential target is the kissing bug, which can spread Chagas disease throughout parts of the Americas.

As harmonic radar technology continues to improve, it could become an important tool for monitoring insect populations and predicting where disease risks may emerge. Better tracking may help researchers respond to threats before outbreaks begin.

Conclusion

Mosquitoes are spreading into new regions as climates change, increasing concerns about mosquito-borne disease. Researchers have developed tiny harmonic radar tags that can track mosquito movements in different environments. Although the technology still faces challenges, it may eventually help predict and prevent disease outbreaks.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of ekamelev.

Malaria remains a devastating disease with major global impact. In 2024, 282 million malaria cases caused over 600,000 deaths. The World Health Organization reported cases across 80 countries. Africa carried 95% of both cases and deaths.

About 75% of malaria cases occurred in children under five. This burden shows how deeply the disease affects vulnerable populations. A new discovery offers hope against this global health crisis.

Researchers identified a protein that helps malaria parasites reproduce. When scientists deactivate this protein, parasite growth drops sharply. This finding could help reduce transmission and lower infection rates.

What is Malaria?

Malaria symptoms begin when protists invade human blood and tissues. Protists are single-celled eukaryotes not classified as animals or plants.

Malaria-causing protists belong to the Plasmodium genus. This genus includes over 150 species infecting many vertebrate animals. Only five Plasmodium species cause malaria in humans.

Anopheles mosquitoes spread malaria between humans and other hosts. These mosquitoes support parasite growth and reproduction cycles. Understanding this process is key to stopping transmission.

Plasmodium parasites reproduce differently than most other eukaryotic organisms. Researchers studied a protein called Aurora-related kinase 1, or ARK1.

What is ARK1?

ARK1 plays a key role in parasite growth and replication. It controls cell activity during reproduction processes. This protein helps parasites build a structure called a spindle. The spindle separates genetic material during new cell formation.

Researchers used gene knockout and gene knockdown methods. These approaches allowed scientists to deactivate the ARK1 gene.

Scientists observed how this change affected parasite growth. Without ARK1, parasites could not form proper spindle structures. This disruption made replication much harder inside host cells.

The same effect appeared in vertebrate hosts and mosquito carriers. Researchers concluded ARK1 is essential for parasite survival.

Targeting ARK1 could help stop malaria transmission cycles. This approach may reduce infections in both humans and mosquitoes.

Scientists noted ARK1 differs greatly from similar human proteins. This difference suggests treatments would likely not harm human cells. That makes ARK1 a strong target for safe drug development.

Future research could develop drugs that block parasite replication effectively. These treatments may stop protozoa without causing harmful side effects.

Researchers from several global institutions contributed to this study. These included the University of Nottingham and National Institute of Immunology. Teams also worked from the University of Groningen and Francis Crick Institute.

The study shows how international cooperation advances medical discoveries. Collaborative research helped uncover a promising malaria treatment target.

Conclusion

Researchers identified ARK1 as a key protein for malaria parasite growth. Disabling this protein stops parasite replication in humans and mosquitoes. This discovery may lead to safer, more effective malaria treatments soon. Many more studies are needed to confirm these early findings.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

Travel can expose people to many valuable new experiences. It offers chances to see new sights, taste new foods, and meet new people. These opportunities may not exist in the same way at home.

However, travel can also expose people to new health risks. Many people in the United States view polio as a past disease. Yet, in some countries, polio transmission still occurs.

Recent reports show the polio virus appearing in several regions worldwide. Some common travel destinations, including the United Kingdom and Germany, now carry risk. In March 2026, the Centers for Disease Control and Prevention issued a level 2 travel notice.

A level 2 notice advises travelers to take extra precautions. It does not suggest canceling or avoiding nonessential travel. Polio continues to circulate across parts of Africa, the Middle East, and Europe.

What is Polio?

Polio is a serious disease that damages the nervous system. It can cause lasting disability and long-term health complications. In severe cases, the disease can lead to permanent paralysis.

Early infection often causes no symptoms in many people. Over time, symptoms begin to appear and gradually worsen. Common symptoms include fever, fatigue, nausea, headaches, and muscle stiffness.

Some cases become severe and lead to dangerous complications. Polio can cause paralysis in the arms, legs, or breathing muscles. Death can occur when breathing muscles stop working and fail completely.

Polio spreads mainly through contaminated food and drinking water sources. The virus can also spread through poor hygiene and unwashed hands. This happens because the virus can live in infected human feces.

How to Protect from Polio

Vaccination remains the most effective way to prevent polio infection. Health experts strongly recommend vaccination before traveling to affected regions. The CDC advises full vaccination for both children and adults.

Adults who completed vaccination may receive a single lifetime booster shot. This booster helps strengthen protection when traveling to high-risk international areas. It is especially recommended where polio still circulates among populations.

People who never started or completed vaccination should do so immediately. Completing the vaccine series provides strong protection against severe disease outcomes. Travelers should plan ahead to ensure full protection before leaving.

Polio rarely appears within the United States due to high vaccination rates. Strong immunization coverage has greatly reduced domestic transmission over time. However, international travel can still increase exposure risk to the virus.

Polio spreads more easily during summer and autumn in temperate regions. Seasonal patterns can influence how quickly outbreaks grow in certain areas. Travelers should stay aware of seasonal risks when planning trips abroad.

In tropical regions, seasonal patterns are less clear and predictable. Transmission can occur throughout the year without strong seasonal trends. This makes consistent prevention measures important in those regions.

The most recent reported U.S. polio case occurred in July 2022. Health officials continue monitoring global cases and potential risks to travelers. Staying informed helps people make safer and more prepared travel decisions.

Conclusion

Polio remains a serious risk in some travel destinations worldwide. Vaccination offers strong protection and is recommended before traveling abroad. Taking simple precautions can reduce risk and help prevent severe illness.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

Sometimes important answers appear in unexpected and surprising places. People often find lost items hidden under cushions or inside drawers. Researchers discovered a similar surprise while studying vitamin D and COVID-19.

Scientists found regular vitamin D intake may reduce Long COVID risk. This finding came from researchers at Mass General Brigham. Their results were published in the Journal of Nutrition.

How Did Research Find the Link?

Earlier studies explored vitamin D because it supports immune system function. However, past research linking vitamin D and COVID-19 showed unclear results. Researchers designed this study to better understand that relationship.

They created the VIVID trial to study vitamin D and COVID-19. The study included adults recently diagnosed with COVID-19 and their families. Participants came from both the United States and Mongolia.

A total of 1,747 adult participants were included in the analysis. Additionally, 277 family members joined the study under separate conditions. These family members received either vitamin D3 supplements or a placebo daily.

Participants took supplements or a placebo for a period of four weeks. Most participants began supplementation about three days after testing positive.

The United States trial ran from December 2020 through September 2022. The Mongolia portion ran from September 2021 through April 2022.

Researchers used randomization to reduce bias across the study groups. They also adjusted for factors that could influence results. These included age, sex, body mass index, race, and ethnicity. Vaccination status was also considered as a possible influencing factor.

The study found no meaningful change in COVID-19 symptom severity. It also showed no reduction in the likelihood of virus transmission.

However, researchers noticed a possible connection to Long COVID outcomes. Participants taking vitamin D showed a slightly lower risk of symptoms.

These long-term symptoms were measured eight weeks after initial infection. Participants taking supplements had a 21 percent chance of symptoms. Those taking a placebo had a 25 percent chance of symptoms.

This represents a 4 percent reduction in Long COVID risk. The difference was considered barely statistically significant by researchers.

What’s Next?

Even so, the findings remain important for future investigation efforts. Long COVID can cause wide-ranging and serious long-term health effects.

Because of this, even small improvements may have meaningful impacts. Researchers believe this signal could guide future clinical studies.

Further research will help confirm whether vitamin D truly reduces risk. Scientists will need larger studies and stronger statistical evidence. For now, the findings offer a cautious but promising direction forward.

Conclusion

Vitamin D supplements did not reduce COVID-19 severity or spread. However, participants showed a small decrease in Long COVID risk. Researchers say more studies are needed to confirm these early findings.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Wikimedia.

When removing contamination, accidents can happen if people are not careful. For example, while dusting an antique bowl, someone might knock over a lamp. The lamp could fall and shatter into pieces.

A similar process can occur in the immune system. When the body responds to infection, mistakes sometimes occur. These errors can trigger cascading negative health effects.

Researchers from University of California, San Francisco recently investigated a link between Epstein–Barr virus (EBV) and Multiple sclerosis (MS). This finding is important because EBV is extremely common. About 96 percent of people become infected during their lifetime. Most infections occur during childhood and cause few symptoms.

In some cases, EBV causes infectious mononucleosis, often called “kissing disease.” MS is a chronic autoimmune disease of the central nervous system. In MS, the immune system attacks myelin surrounding nerve fibers. Myelin is a fatty, protein-rich layer that protects nerve signals. Nearly one million Americans currently live with MS.

What Links EBV and MS?

The research team published its study on February 5 in Nature Immunology. The study revealed unusually high levels of certain immune cells. These cells are called CD8-positive killer T cells. They destroy infected or defective cells.

Researchers observed these cells more frequently in people with MS. Many of the cells targeted EBV-infected cells specifically. Because of this pattern, scientists suspect EBV may trigger immune dysfunction.

Most previous MS research focused on CD4-positive T cells. These cells activate immune responses but do not destroy cells directly. They are also easier to study in animal models.

The UCSF researchers used a different strategy. They examined killer T cells in people with MS. Scientists analyzed blood and cerebrospinal fluid, also called CSF. The study included 13 patients with MS or possible symptoms. Five additional participants without MS served as comparison subjects.

After organizing the data, researchers searched for killer T cells targeting proteins. Participants without MS showed similar protein levels in blood and CSF. However, MS patients showed ten to one hundred times more proteins in CSF.

Researchers also examined EBV-related genetic activity. Because EBV infects most people, the virus appeared in many samples. However, one active gene appeared only in individuals with MS. Scientists believe this gene may drive immune dysfunction linked to MS.

Earlier studies have also linked EBV to other autoimmune diseases. These include lupus, rheumatoid arthritis, and Long COVID. Another study examined more than 10 million individuals. Researchers found a 32-fold higher MS risk after EBV infection. A separate study in 2024 found increased EBV-targeting T cells in MS patients. Together, these findings strengthen evidence connecting EBV and MS.

Conclusion

Researchers found strong evidence linking Epstein-Barr virus infection to multiple sclerosis. The virus may trigger immune cells that mistakenly attack protective nerve tissue. These findings could guide future research toward preventing or treating multiple sclerosis.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.